It seems this was primarily caused by a report that a number of senior executives at the pharma company’s China unit could be implicated in a major insurance fraud case. Last week, AstraZeneca said ...

AstraZeneca's shares have fallen more than 8% on speculation about an anti-corruption probe in China, its second-largest ...

AstraZeneca shares dropped Tuesday after a report that dozens of the company’s senior executives in China potentially have ...

EUROPE’S Stoxx 600 eked out minor gains on Tuesday led by gains in industrials as investors assessed a slew of downbeat earnings and kept a close eye on voting in a tightly contested U.S. presidential ...

BofA notes that AstraZeneca (AZN) shares are down greater than 10% in the last few days on the back of China concerns around the ongoing ...

Astra saw £14.4bn wiped off its value after Chinese media said dozens of managers were implicated in a scandal.

Shares of AstraZeneca (AZN) are lower as more headlines emerge on the scope of the ongoing China probe of the company’s China president, ...

AstraZeneca's (NASDAQ:AZN) selloff on Tuesday in response to reports that the company is facing a fraud investigation in ...

The FTSE 100 was dented by a hefty fall for AstraZeneca after reports from China that dozens of the pharmaceutical company’s ...

AstraZeneca’s stock price dropped by 8.4% during Tuesday’s trading in London after a report fueled fears of a potentially ...

AstraZeneca shares fell 8% in London Tuesday, the biggest drop in four years following a fresh report that a Chinese investigation of the company has widened. AstraZeneca said last week that its China ...

AstraZeneca said on Tuesday that it does not comment on speculative media reports, in response to a sharp drop in its share ...